JNJ 49095397 (RV568)

JNJ 49095397 (RV568) · Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ 49095397 (RV568), covering 2019-08-21 to 2019-08-21. Get the full timeline:

Most recent: Clinical Trial Update: An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease [Phase 2]

See pricing